Single-inhaler triple versus dual bronchodilator therapy in COPD: real-world comparative effectiveness and safety
Purpose Randomized trials report that single-inhaler triple therapy is more effective than
dual bronchodilators at reducing exacerbations in patients with chronic obstructive …
dual bronchodilators at reducing exacerbations in patients with chronic obstructive …
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
A Koarai, M Yamada, T Ichikawa, N Fujino… - Respiratory …, 2021 - Springer
Background Recently, the addition of inhaled corticosteroid (ICS) to long-acting muscarinic
antagonist (LAMA) and long-acting beta-agonist (LABA) combination therapy has been …
antagonist (LAMA) and long-acting beta-agonist (LABA) combination therapy has been …
Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world'study
CF Vogelmeier, H Worth, R Buhl, CP Criée… - Respiratory …, 2022 - Springer
Introduction Chronic obstructive pulmonary disease (COPD) guidelines recommend
reserving triple therapy of inhaled corticosteroid (ICS), long-acting β2-agonist (LABA) and …
reserving triple therapy of inhaled corticosteroid (ICS), long-acting β2-agonist (LABA) and …
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind …
D Singh, A Papi, M Corradi, I Pavlišová, I Montagna… - The Lancet, 2016 - thelancet.com
Background Few data are available for the efficacy of" triple therapy" with two long-acting
bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease …
bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease …
[PDF][PDF] Triple therapy vs. triple therapy in COPD
JL Lopez-Campos, E Marquez-Martín… - Arch …, 2017 - researchgate.net
The combination of 2 long-acting bronchodilators, a 2-agonist (LABA), and an
antimuscarinic agent (LAMA) in a single inhalation device, known as double …
antimuscarinic agent (LAMA) in a single inhalation device, known as double …
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
LEGW Vanfleteren, A Ullman, A Nordenson… - ERJ Open …, 2019 - Eur Respiratory Soc
A current hot topic in COPD is that two “fixed triple” combinations of an inhaled corticosteroid
(ICS), a long-acting β2-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) in a …
(ICS), a long-acting β2-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) in a …
Fluticasone-based versus budesonide-based triple therapies in COPD: real-world comparative effectiveness and safety
Triple therapy for chronic obstructive pulmonary disease (COPD) is recommended for some
patients, but the inhaled corticosteroids (ICS) may differ in effectiveness and safety. We …
patients, but the inhaled corticosteroids (ICS) may differ in effectiveness and safety. We …
Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease
D Singh - Expert opinion on pharmacotherapy, 2018 - Taylor & Francis
Introduction: Chronic obstructive pulmonary disease (COPD) management focuses on the
alleviation of symptoms and prevention of exacerbations. Inhaled long acting …
alleviation of symptoms and prevention of exacerbations. Inhaled long acting …
Triple combinations in chronic obstructive pulmonary disease–is three better than two?
M Cazzola, MG Matera - Expert Opinion on Pharmacotherapy, 2014 - Taylor & Francis
A growing body of evidence suggests that triple therapy with an antimuscarinic agent, a long-
acting β2-agonist, and an inhaled corticosteroid is efficacious in patients with more severe …
acting β2-agonist, and an inhaled corticosteroid is efficacious in patients with more severe …